Research Industries (US) and Cobe in cardiovascular tie-up
This article was originally published in Clinica
Research Industries (US) believes that a distribution agreement signed with Cobe, the US subsidiary of Swedish Gambro Group, last week will generate $1 million in incremental revenues in the first year. Cobe will bundle Research's catheters in its oxygen bypass tubing circuits in the US. In international markets Cobe will replace its own line of bypass circuitry catheters with Research's specialty cardiovascular devices.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.